Please login to the form below

Not currently logged in
Email:
Password:

Colobreathe

This page shows the latest Colobreathe news and features for those working in and with pharma, biotech and healthcare.

NICE gives final ‘yes’ to cystic fibrosis drugs from Novartis and Forest

NICE gives final ‘yes’ to cystic fibrosis drugs from Novartis and Forest

NICE backs Tobi Podhaler and Colobreathe for NHS use. Cystic fibrosis patients in England and Wales will now have access to two new drugs from Novartis and Forest Laboratories to treat ... The limited recommendation takes into account that the Tobi

Latest news

  • NICE backs two cystic fibrosis treatments for NHS use NICE backs two cystic fibrosis treatments for NHS use

    NICE backs two cystic fibrosis treatments for NHS use. Novartis’ Tobi Podhaler and Forest’ s Colobreathe recommended at discounted price. ... Novartis' Tobi Podhaler and Forest Laboratories' Colobreathe have both received backing for use in the NHS

  • NICE backs Novartis’ Tobi Podhaler in cystic fibrosis NICE backs Novartis’ Tobi Podhaler in cystic fibrosis

    NICE backs Novartis’ Tobi Podhaler in cystic fibrosis. But draft guidance doesn't recommend Forest’ s Colobreathe. ... The Institute took a less positive stance on Forest's application for the use of Colobreathe for the treatment of chronic pulmonary

More from news
Approximately 3 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CAN advertising

Brief us and you’ll soon see we really CAN do it all. We’re different to other agencies. You’ll get expert...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics